© 2023 The American Journal of Medicine Blog. All Rights Reserved.
Pharmaceutical Industry
What's New from AJM
Why California’s Proposition 61 Was a Bad Idea
New approaches to control state pharmaceutical costs are needed.1Â This issue is particularly critical in California, the state with the largest pharmaceutical expenditures in the country.1Â A controversial California ballot initiative aimed at reining in prescription drug expenditures was defeated on November 8, 2016 by a 54% to 46% margin.2The California Drug Price Relief Act, also known as Proposition 61, sought...
LATEST VIDEOS
AJM Announces Long COVID Series & New Podcast
01:45
Are Prisoners Good Hospital Patients?
01:59
Improving Care for Orthopedic Surgery Patients
00:41
Orthopedic Surgery + Internal Medicine Co-Management of Patients
01:28
We Need New Strategies to Prevent Lyme Disease
01:00
Patient Communication Strategies from an Italian Barber
01:00
Effects of Long COVID
00:54
Long COVID Brings Functional Limitations
01:24
Using Pet Scans to Diagnose Infections
00:35
Can We Blame Texting for Our Lack of Empathy?
01:00
GLP-1 + Glucose Blocker: Combo Therapy Improves Weight Loss & More
03:08
Should Statins Be Prescribed for Older Adults?
01:38